AI will cure cancer in our lifetime, claims boss of UK chip giant

by | Sep 8, 2026 | Top Stories

AI will cure cancer in our lifetime, claims boss of UK chip giant

Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings, has stated that artificial intelligence will develop cancer treatments that humans cannot discover independently during current lifetimes. He characterized the modeling of DNA markers and their relationship to cancer as a problem currently beyond both human and current computer capabilities, but expressed confidence that advancing AI systems will eventually solve it as they process increasingly sophisticated data.

Haas also predicted widespread deployment of humanoid robots equipped with self-learning capabilities within five years, particularly in manufacturing, security, construction, and service industries. He noted that AI-powered robots would gain the ability to learn new tasks dynamically, potentially allowing machines trained for one function to adapt to others. When addressing concerns about job displacement, Haas suggested that estimates of massive employment losses are exaggerated and would be offset by new opportunities created by the technology.

The executive highlighted that Arm’s power-efficient microchip designs now power approximately half of global AI data centers, representing a significant evolution in the company’s business model. He noted substantial demand for Arm’s AGI chip developed for Meta since its March launch, with over $2 billion in orders accumulated. However, Haas identified chip supply shortages as a significant constraint limiting AI infrastructure expansion and data center development globally.

Regarding UK manufacturing capabilities, Haas expressed skepticism about establishing chip fabrication facilities domestically, citing the substantial costs, specialized workforce requirements, and resource demands involved. He contended that existing global supply chains, currently centered on Taiwan’s TSMC, adequately serve the industry’s needs. Haas reaffirmed Arm’s commitment to the UK, noting that half of the company’s employees remain based there and describing it as Cambridge’s largest employer.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI